Skip to main content
Top
Published in: BMC Oral Health 1/2014

Open Access 01-12-2014 | Research article

The relationship between ezrin and podoplanin expressions in keratocystic odontogenic tumors

Authors: Denise Tostes Oliveira, Laís Priscila de Santis, Agnes Assao, Kellen Cristine Tjioe, Suely Nonogaki, José Roberto Pereira Lauris, Fernando Augusto Soares

Published in: BMC Oral Health | Issue 1/2014

Login to get access

Abstract

Background

The aims of this study were to investigate the immunolocalization of ezrin and its relationship with the podoplanin expression in keratocystic odontogenic tumors.

Material and Methods

The immunohistochemical expressions of ezrin and podoplanin by odontogenic epithelium were evaluated in keratocystic odontogenic tumors using monoclonal antibodies.

Results

Our results showed strong cytoplasmic ezrin and membranous podoplanin expressions in basal epithelial layer of all keratocystic odontogenic tumors. The cytoplasmic and membranous ezrin expressions were also detected in suprabasal epithelial layers of tumors. Statistically significant difference between cellular immunolocalization of ezrin and podoplanin odontogenic epithelium were found by Wilcoxon’s test (p < 0.05). No correlation between both proteins in keratocystic odontogenic tumors was detected by Spearman test.

Conclusions

These results suggest that ezrin and podoplanin may contribute to the expansive growth and local invasiveness of keratocystic odontogenic tumors. Additionally, as both proteins were overexpressed by odontogenic epithelium, their possible roles need to be further explored in benign odontogenic tumors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sawa Y, Iwasawa K, Ishikawa H:Expression of podoplanin in the mouse tooth germ and apical bud cells. Acta Histochem Cytochem. 2008, 41: 121-126. 10.1267/ahc.08019.CrossRefPubMedPubMedCentral Sawa Y, Iwasawa K, Ishikawa H:Expression of podoplanin in the mouse tooth germ and apical bud cells. Acta Histochem Cytochem. 2008, 41: 121-126. 10.1267/ahc.08019.CrossRefPubMedPubMedCentral
2.
go back to reference Imaizumi Y, Amano I, Tsuruga E, Kojima H, Sawa Y:Immunohistochemical examination for the distribution of podoplanin-expressing cells in developing mouse molar tooth germs. Acta Histochem Cytochem. 2010, 43: 115-121. 10.1267/ahc.10023.CrossRefPubMedPubMedCentral Imaizumi Y, Amano I, Tsuruga E, Kojima H, Sawa Y:Immunohistochemical examination for the distribution of podoplanin-expressing cells in developing mouse molar tooth germs. Acta Histochem Cytochem. 2010, 43: 115-121. 10.1267/ahc.10023.CrossRefPubMedPubMedCentral
3.
go back to reference González-Alva P, Tanaka A, Oku Y, Miyazaki Y, Okamoto E, Fujinami M, Yoshida N, Kikuchi K, Ide F, Sakashita H, Kusama K:Enhanced expression of podoplanin in ameloblastomas. J Oral Pathol Med. 2010, 39: 103-109. 10.1111/j.1600-0714.2009.00818.x.CrossRefPubMed González-Alva P, Tanaka A, Oku Y, Miyazaki Y, Okamoto E, Fujinami M, Yoshida N, Kikuchi K, Ide F, Sakashita H, Kusama K:Enhanced expression of podoplanin in ameloblastomas. J Oral Pathol Med. 2010, 39: 103-109. 10.1111/j.1600-0714.2009.00818.x.CrossRefPubMed
4.
go back to reference Okamoto E, Kikuchi K, Miyazaki Y, Gonzalez-Alva P, Oku Y, Tanaka A, Yoshida N, Fujinami M, Ide F, Sakashita H, Kusama K:Significance of podoplanin expression in keratocystic odontogenic tumor. J Oral Pathol Med. 2010, 39: 110-114. 10.1111/j.1600-0714.2009.00851.x.CrossRefPubMed Okamoto E, Kikuchi K, Miyazaki Y, Gonzalez-Alva P, Oku Y, Tanaka A, Yoshida N, Fujinami M, Ide F, Sakashita H, Kusama K:Significance of podoplanin expression in keratocystic odontogenic tumor. J Oral Pathol Med. 2010, 39: 110-114. 10.1111/j.1600-0714.2009.00851.x.CrossRefPubMed
5.
go back to reference Zustin J, Scheuer HA, Friedrich RE:Podoplanin expression in human tooth germ tissues and cystic odontogenic lesions: an immunohistochemical study. J Oral Pathol Med. 2010, 39: 115-120. 10.1111/j.1600-0714.2009.00853.x.CrossRefPubMed Zustin J, Scheuer HA, Friedrich RE:Podoplanin expression in human tooth germ tissues and cystic odontogenic lesions: an immunohistochemical study. J Oral Pathol Med. 2010, 39: 115-120. 10.1111/j.1600-0714.2009.00853.x.CrossRefPubMed
6.
go back to reference Gonzalez-Alva P, Inoue H, Miyazaki Y, Tsuchiya H, Noguchi Y, Kikuchi K, Ide F, Ishihara S, Katayama T, Sakashita H, Kusama K:Podoplanin expression in odontomas: clinicopathological study and immunohistochemical analysis of 86 cases. J Oral Sci. 2011, 53: 67-75. 10.2334/josnusd.53.67.CrossRefPubMed Gonzalez-Alva P, Inoue H, Miyazaki Y, Tsuchiya H, Noguchi Y, Kikuchi K, Ide F, Ishihara S, Katayama T, Sakashita H, Kusama K:Podoplanin expression in odontomas: clinicopathological study and immunohistochemical analysis of 86 cases. J Oral Sci. 2011, 53: 67-75. 10.2334/josnusd.53.67.CrossRefPubMed
7.
go back to reference Tjioe KC, Oliveira DT, Soares CT, Lauris JR, Damante JH:Is podoplanin expression associated with the proliferative activity of ameloblastomas?. Oral Dis. 2012, 18: 673-679. 10.1111/j.1601-0825.2012.01924.x.CrossRefPubMed Tjioe KC, Oliveira DT, Soares CT, Lauris JR, Damante JH:Is podoplanin expression associated with the proliferative activity of ameloblastomas?. Oral Dis. 2012, 18: 673-679. 10.1111/j.1601-0825.2012.01924.x.CrossRefPubMed
8.
go back to reference Friedrich RE, Scheuer HA, Zustin J:Expression of podoplanin in nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumours. Anticancer Res. 2012, 32: 2125-2127.PubMed Friedrich RE, Scheuer HA, Zustin J:Expression of podoplanin in nevoid basal cell carcinoma syndrome-associated keratocystic odontogenic tumours. Anticancer Res. 2012, 32: 2125-2127.PubMed
9.
go back to reference Caetano Ados S, Tjioe KC, Faustino SE, Hanemann JA, Belone Ade F, Soares CT, Oliveira DT:Immunolocalization of podoplanin in benign odontogenic tumours with and without ectomesenchyme. Arch Oral Biol. 2013, 58: 408-415. 10.1016/j.archoralbio.2012.06.002.CrossRefPubMed Caetano Ados S, Tjioe KC, Faustino SE, Hanemann JA, Belone Ade F, Soares CT, Oliveira DT:Immunolocalization of podoplanin in benign odontogenic tumours with and without ectomesenchyme. Arch Oral Biol. 2013, 58: 408-415. 10.1016/j.archoralbio.2012.06.002.CrossRefPubMed
10.
go back to reference Zhang X, Wang J, Ding X, Xing S, Zhang W, Wang L, Wu H, Wang L:Altered expression of podoplanin in keratocystic odontogenic tumours following decompression. Oncol Lett. 2014, 7: 627-630.PubMed Zhang X, Wang J, Ding X, Xing S, Zhang W, Wang L, Wu H, Wang L:Altered expression of podoplanin in keratocystic odontogenic tumours following decompression. Oncol Lett. 2014, 7: 627-630.PubMed
11.
go back to reference Martin-Villar E, Fernandez-Munoz B, Parsons M, Yurrita MM, Megias D, Perez-Gomez E, Jones GE, Quintanilla M:Podoplanin associates with CD44 to promote directional cell migration. Mol Biol Cell. 2010, 21: 4387-4399. 10.1091/mbc.E10-06-0489.CrossRefPubMedPubMedCentral Martin-Villar E, Fernandez-Munoz B, Parsons M, Yurrita MM, Megias D, Perez-Gomez E, Jones GE, Quintanilla M:Podoplanin associates with CD44 to promote directional cell migration. Mol Biol Cell. 2010, 21: 4387-4399. 10.1091/mbc.E10-06-0489.CrossRefPubMedPubMedCentral
12.
go back to reference Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G:Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell. 2006, 9: 261-272. 10.1016/j.ccr.2006.03.010.CrossRefPubMed Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G:Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer Cell. 2006, 9: 261-272. 10.1016/j.ccr.2006.03.010.CrossRefPubMed
13.
go back to reference Martin-Villar E, Megias D, Castel S, Yurrita MM, Vilaro S, Quintanilla M:Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci. 2006, 119: 4541-4553. 10.1242/jcs.03218.CrossRefPubMed Martin-Villar E, Megias D, Castel S, Yurrita MM, Vilaro S, Quintanilla M:Podoplanin binds ERM proteins to activate RhoA and promote epithelial-mesenchymal transition. J Cell Sci. 2006, 119: 4541-4553. 10.1242/jcs.03218.CrossRefPubMed
14.
go back to reference Arpin M, Chirivino D, Naba A, Zwaenepoel I: Emerging role for ERM proteins in cell adhesion and migration. Cell Adh Migr. 2011, 5: 199-206. 10.4161/cam.5.2.15081.CrossRefPubMedPubMedCentral Arpin M, Chirivino D, Naba A, Zwaenepoel I: Emerging role for ERM proteins in cell adhesion and migration. Cell Adh Migr. 2011, 5: 199-206. 10.4161/cam.5.2.15081.CrossRefPubMedPubMedCentral
15.
go back to reference Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G:Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med. 2004, 10: 175-181. 10.1038/nm966.CrossRefPubMed Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, Merlino G:Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med. 2004, 10: 175-181. 10.1038/nm966.CrossRefPubMed
16.
go back to reference Barnes LEJW, Reichart P, Sidransky D: Odontogenic Tumors. World Health Organization Classification of Tumours - Pathology and genetics - Head and neck Tumours. 2005, Lyon, France: IARC Press I, 284-327. Barnes LEJW, Reichart P, Sidransky D: Odontogenic Tumors. World Health Organization Classification of Tumours - Pathology and genetics - Head and neck Tumours. 2005, Lyon, France: IARC Press I, 284-327.
17.
go back to reference Tsuneki M, Maruyama S, Yamazaki M, Cheng J, Saku T:Podoplanin expression profiles characteristic of odontogenic tumor-specific tissue architectures. Pathol Res Pract. 2012, 208: 140-146. 10.1016/j.prp.2011.12.016.CrossRefPubMed Tsuneki M, Maruyama S, Yamazaki M, Cheng J, Saku T:Podoplanin expression profiles characteristic of odontogenic tumor-specific tissue architectures. Pathol Res Pract. 2012, 208: 140-146. 10.1016/j.prp.2011.12.016.CrossRefPubMed
18.
go back to reference Madan R, Brandwein-Gensler M, Schlecht NF, Elias K, Gorbovitsky E, Belbin TJ, Mahmood R, Breining D, Qian H, Childs G, Locker J, Smith R, Haigentz M, Gunn-Moore F, Prystowsky MB:Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma. Head Neck. 2006, 28: 1018-1027. 10.1002/hed.20435.CrossRefPubMed Madan R, Brandwein-Gensler M, Schlecht NF, Elias K, Gorbovitsky E, Belbin TJ, Mahmood R, Breining D, Qian H, Childs G, Locker J, Smith R, Haigentz M, Gunn-Moore F, Prystowsky MB:Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma. Head Neck. 2006, 28: 1018-1027. 10.1002/hed.20435.CrossRefPubMed
19.
go back to reference Mhawech-Fauceglia P, Dulguerov P, Beck A, Bonet M, Allal AS:Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy. J Clin Pathol. 2007, 60: 185-189.CrossRefPubMed Mhawech-Fauceglia P, Dulguerov P, Beck A, Bonet M, Allal AS:Value of ezrin, maspin and nm23-H1 protein expressions in predicting outcome of patients with head and neck squamous-cell carcinoma treated with radical radiotherapy. J Clin Pathol. 2007, 60: 185-189.CrossRefPubMed
20.
go back to reference Saito S, Yamamoto H, Mukaisho K, Sato S, Higo T, Hattori T, Yamamoto G, Sugihara H:Mechanisms underlying cancer progression caused by ezrin overexpression in tongue squamous cell carcinoma. PLoS ONE. 2013, 8: e54881-10.1371/journal.pone.0054881.CrossRefPubMedPubMedCentral Saito S, Yamamoto H, Mukaisho K, Sato S, Higo T, Hattori T, Yamamoto G, Sugihara H:Mechanisms underlying cancer progression caused by ezrin overexpression in tongue squamous cell carcinoma. PLoS ONE. 2013, 8: e54881-10.1371/journal.pone.0054881.CrossRefPubMedPubMedCentral
21.
go back to reference Schlecht NF, Brandwein-Gensler M, Smith RV, Kawachi N, Broughel D, Lin J, Keller CE, Reynolds PA, Gunn-Moore FJ, Harris T, Childs G, Belbin TJ, Prystowsky MB:Cytoplasmic ezrin and moesin correlate with poor survival in head and neck squamous cell carcinoma. Head Neck Pathol. 2012, 6: 232-243. 10.1007/s12105-011-0328-1.CrossRefPubMedPubMedCentral Schlecht NF, Brandwein-Gensler M, Smith RV, Kawachi N, Broughel D, Lin J, Keller CE, Reynolds PA, Gunn-Moore FJ, Harris T, Childs G, Belbin TJ, Prystowsky MB:Cytoplasmic ezrin and moesin correlate with poor survival in head and neck squamous cell carcinoma. Head Neck Pathol. 2012, 6: 232-243. 10.1007/s12105-011-0328-1.CrossRefPubMedPubMedCentral
22.
go back to reference dos Santos AA, Oliveira DT, Pereira MC, Faustino SE, Nonogaki S, Carvalho AL, Kowalski LP:Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance. Anticancer Res. 2013, 33: 3969-3976. dos Santos AA, Oliveira DT, Pereira MC, Faustino SE, Nonogaki S, Carvalho AL, Kowalski LP:Podoplanin and VEGF-C immunoexpression in oral squamous cell carcinomas: prognostic significance. Anticancer Res. 2013, 33: 3969-3976.
Metadata
Title
The relationship between ezrin and podoplanin expressions in keratocystic odontogenic tumors
Authors
Denise Tostes Oliveira
Laís Priscila de Santis
Agnes Assao
Kellen Cristine Tjioe
Suely Nonogaki
José Roberto Pereira Lauris
Fernando Augusto Soares
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Oral Health / Issue 1/2014
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/1472-6831-14-150

Other articles of this Issue 1/2014

BMC Oral Health 1/2014 Go to the issue